Product Description: Libenzapril (Abutapril; CGS-16617) is an orally active, potent direct-acting angiotensin-converting-enzyme (ACE) inhibitor. Libenzapril has the potential for ischemia-induced heart failure research[1].
Formula: C18H25N3O5
References: [1]E F Smith 3rd, et al. Effects of two nonsulfhydryl angiotensin-converting enzyme inhibitors, CGS 14831 and CGS 16617, on myocardial damage and left-ventricular hypertrophy following coronary artery occlusion in the rat. Pharmacology. 1988;37(4):254-63.
CAS Number: 109214-55-3
Molecular Weight: 363.41
Research Area: Endocrinology; Cardiovascular Disease
Target: Angiotensin-converting Enzyme (ACE)